ANTI-CD19 BITE BLINATUMOMAB INDUCES HIGH COMPLETE REMISSION RATE IN ADULT PATIENTS WITH RELAPSED B-PRECURSOR ALL: UPDATED RESULTS OF AN ONGOING PHASE II TRIAL

Goekbuget, N. and Topp, M. S. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. and Reichle, A. and Marks, R. and Brueggemann, M. and Ritgen, M. and Klappers, P. and Mergen, N. and Goebeler, M. E. and Einsele, H. and Hoelzer, D. and Bargou, R. (2012) ANTI-CD19 BITE BLINATUMOMAB INDUCES HIGH COMPLETE REMISSION RATE IN ADULT PATIENTS WITH RELAPSED B-PRECURSOR ALL: UPDATED RESULTS OF AN ONGOING PHASE II TRIAL. ANNALS OF ONCOLOGY, 23 (Suppl1). i20-i21. ISSN 0923-7534

Full text not available from this repository.

Item Type:	Article
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User:	Petra Gürster
Date Deposited:	11 May 2020 08:34
Last Modified:	11 May 2020 08:34
URI:	https://pred.uni-regensburg.de/id/eprint/19073

Actions (login required)

View Item